Metformin: still the sweet spot for CV protection in diabetes?
Sign Up to like & getrecommendations! Published in 2020 at "Current opinion in pharmacology"
DOI: 10.1016/j.coph.2020.10.018
Abstract: Metformin remains the first-line drug treatment for type 2 diabetes (T2D) in most guidelines not only because it achieves significant reduction in HbA1c but also because of a wealth of clinical experience regarding its safety… read more here.
Keywords: metformin still; metformin; protection diabetes; still sweet ... See more keywords